Tue.Mar 25, 2025

article thumbnail

Opinion: 23andMe’s bankruptcy doesn’t diminish its impact

STAT

23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.

291
291
article thumbnail

The industry heavyweight behind Novavax’s push to bounce back

PharmaVoice

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

Vaccines 284
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Does the kidney transplant system need to change?

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! It was quite a rainy day in Boston yesterday — but at least it wasn’t a cold one. I’m manifesting some sun for today.

201
201
article thumbnail

Is my Pharma Marketing Job Going to Be Eliminated?

Pharma Marketing Network

Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.

59
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Biogen plots new global headquarters in Kendall Square

PharmaVoice

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

130
130

More Trending

article thumbnail

Healthcare Business Intelligence (BI): Comprehensive Guide

Viseven

There is one thing that can completely change how healthcare organizations approach their patients. It’s data. And one of the best ways to manage and use it for insights is business intelligence. In healthcare, business intelligence tools play a far more critical role than might initially seem. These tools often hold the key to solving challenges and addressing the situations, where timely access to data is paramount.

article thumbnail

Cadila Pharma launches Cadilose, a lactulose solution for constipation and hepatic encephalopathy

Express Pharma

Cadila Pharmaceuticals has launched Cadilose, an advanced Lactulose formulation designed to effectively manage constipation and hepatic encephalopathy (HE). Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the intestines and promotes smooth bowel movements. It also functions as a prebiotic, encouraging the growth of beneficial gut bacteria.

59
article thumbnail

FDA starts review of Sanofi's MS hope tolebrutinib

pharmaphorum

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis

101
101
article thumbnail

UK downgrades mpox from ‘high consequence infectious disease’ status

The Pharmacist

Clade Ia and Ib mpox has been downgraded from a high consequence infectious disease in the UK, public health officials have confirmed. A review by the Advisory Committee on Dangerous Pathogens found that clade I mpox no longer meets the criteria as a high consequence infectious disease defined as having a high mortality rate and […] The post UK downgrades mpox from high consequence infectious disease status appeared first on The Pharmacist.

40
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Character Biosciences raises $93M with an eye on vision loss drugs

BioPharma Dive

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed geographic atrophy medicines.

78
article thumbnail

UK weight loss market: M&A opportunities

pharmaphorum

Explore the latest M&A opportunities in the UK weight loss market, including market access for products like Wegovy and Mounjaro. Stay informed about key trends and opportunities in the industry.

64
article thumbnail

Merck bets $200M on a new type of heart pill

BioPharma Dive

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a genetic risk factor called lipoprotein(a).

75
article thumbnail

GSK taps into UK health data for dementia study

pharmaphorum

GSK joins with two UK research organisations to explore a possible link between its shingles vaccine Shingrix and a reduced risk of dementia.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

GSK and UK researchers plan to study Shingrix and dementia risk reduction link

Pharmaceutical Technology

The study will analyse electronic health records of 65- and 66-year olds from the UKs National Health Service (NHS).

59
article thumbnail

AbbVie sues Genmab, claiming trade secrets theft

pharmaphorum

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets

64
article thumbnail

Examining Healthcare Spending Across US Counties

Pharmaceutical Commerce

What drivers impact the differences in expenditures?

59
article thumbnail

WuXi AppTec sells UK-US units, but annual results show foreign contracts continue despite China tensions

Pharmaceutical Technology

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

59
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharma Pulse 3/25/25: Identifying Affordability Issues with Predictive Analytics, Novo Nordisk Extends Lowered Wegovy Price to Retail Pharmacies & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

59
article thumbnail

New tool to boost cancer immunotherapy effects

World Pharma News

Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot overcome the tumours defense mechanism and the cancer grows. Now, a study published in Nature Immunology, with the involvement of the Hospital del Mar Research Institute, the Universitat Autnoma de Barcelona and the Pompeu Fabra University, proposes a new approach to strengthen NK cells in their fight a

article thumbnail

MSD licenses Lp(a) heart drug from Hengrui in $2bn deal

pharmaphorum

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront

57
article thumbnail

AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

PharmaTech

Under the agreement, AstraZeneca will use Alteogens proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

52
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

5 ways to address pricing and access challenges across the European landscape

pharmaphorum

EVERSANA discuss 5 effective strategies for overcoming pricing and access challenges in the European healthcare landscape. Learn about HTA, risk-sharing, data utilisation, orphan drugs, and more.

52
article thumbnail

Benuvia Awarded NIH Contract for GMP Synthesis of Psilocybin, Other Drug Substances

PharmaTech

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.

52
article thumbnail

Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist

PharmExec

Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.

article thumbnail

Drug Solutions Podcast: Equipment Trends for Addressing Production of New Modalities

PharmaTech

The growing development of new biotherapeutic modalities will rely heavily on automation and progressive technologies.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.